![](https://endpts.com/wp-content/uploads/2018/04/Badrul-Chowdbury-FDA-AZN-1.jpg)
Badrul Chowdhury jumps ship at the FDA and moves to AstraZeneca, joining an exodus of agency officials
Twenty-year FDA veteran Badrul Chowdhury, most recently director of the Center for Drug Evaluation and Research’s (CDER) Division of Pulmonary, Allergy and Rheumatology Products, has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.